16 April 2021

PhD Positions: Call for Applications

Projects starting October 1st, 2021
Application deadline: May 5th, 2021

The PhD Programs “Molecular Medicine” (MolMed), “Advanced Medical Biomarker Research” (AMBRA), "Metabolic and Cardiovascular Disease" (DK-MCD), “Inflammatory Disorders in Pregnancy” (DP-IDP) and the Doctoral Program “Immune Modulation in Respiratory Diseases” (RESPImmun) open a new call for PhD positions. The Medical University of Graz offers an excellence PhD study program that provides an in-depth, multidisciplinary training in biomedical research in a stimulating international environment.

The thesis projects focus on aspects and new concepts of inflammation, cancer and metabolic, cardiovascular as well as respiratory diseases utilizing a wide spectrum of state-of-the-art techniques. Fields of research combine basic, translational and clinical approaches bridging areas from physiology, pathobiology, immunology and pharmacology.


Selected PhD students will be employed for up to 3 years (initial contract for one year with the option of prolongation upon successful performance) with a contract that includes social benefits. Moreover, students will be encouraged to spend up to one year abroad joining other collaborating laboratories with the possibility of a 4th year extension of their contract.


Applicants must hold (or be close to obtaining) an undergraduate degree equivalent to a Master in any discipline of natural or life sciences or medicine. The selection procedure, all training activities and communications will be in English. Thus, excellent written and spoken English skills are required.


Applications are exclusively accepted through the online platform. Please refrain from contacting the supervisors and do not send any documents by regular mail or e-mail unless you are explicitly asked to do so by our staff. There is no application fee.

For further information about the programs, open projects and the online application procedure, please see  The Medical University of Graz homepage.